Honghui Hu of Wanhuida Intellectual Property considers the impact of the structure-activity relationship on the inventiveness assessment of pharmaceutical compounds Bayer Intellectual Property GmbH ...
“Reactive Noble-Gas Compounds Explored by 3D Electron Diffraction: XeF 2 −MnF 4 Adducts and a Facile Sample Handling Procedure” Since Bartlett’s discovery, which is commemorated with an International ...
A pilot study has developed a new sensory evaluation method that links the chemical structures of polyphenols with their distinct taste properties. Using trained human panelists, researchers showed ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
The universe is flooded with billions of chemicals, each a tiny pinprick of potential. And we’ve only identified 1% of them. Scientists believe undiscovered chemical compounds could help remove ...
Organic chemistry features a wide array of reactions for creating complex molecules, among which the Diels–Alder reaction stands out for its versatility and precision. This reaction enables the ...
Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.
Medicinal chemistry, also known as pharmaceutical chemistry, is a branch of chemistry focused on the development of new drugs and the improvement of existing ones. It is an interdisciplinary field ...
Noble gases have a reputation for being unreactive, inert elements, but more than 60 years ago Neil Bartlett demonstrated the first way to bond xenon. He created XePtF6, an orange-yellow solid.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results